Infinity Provides Key 2014 Goals and Financial Guidance Wall Street Journal An investigator-sponsored Phase 1b, open-label study of IPI-145 in patients with B-cell NHL, CLL and T-cell lymphoma in combination with rituximab (a monoclonal antibody therapy), bendamustine (a chemotherapy) or both rituximab and bendamustine is ... Infinity Pharma (INFI) Updates FY14 Financial Expectations, Pipeline Goals |
